{"database": "lobbying", "table": "lobbying_activities", "rows": [[754074, "be9e13c5-c650-4826-9e96-d2cbfe2ce27c", "Q1", "OGR", 48827, "TAKEDA PHARMACEUTICALS AMERICA INC", 2009, "first_quarter", "MED", "General issues related to the pharmaceutical industry and diabetes care.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2009-04-16T16:05:38-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["754074"], "units": {}, "query_ms": 0.4881260101683438, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}